Introduction
Human breast cancer is a genetically heterogeneous disease that has a highly varied natural history. In some patients, breast cancer is an indolent disease that can progress clinically over periods of 10 to 20 years. In other patients, breast cancer is very aggressive, with rapid clinical progression that results in death within short times after diagnosis of the primary tumor. Such clinical diversity likely has a genetic basis, which underscores the need to improve our understanding of breast cancer genes and how they function to transform HME cells.
The natural history of human breast cancer appears to be dierent in pre-menopausal women compared to post-menopausal women. Whereas estrogen receptor (ER) and progesterone receptor (PR) positivity and a more slowly progressing course characterize postmenopausal breast cancer, pre-menopausal breast cancer tends to be ER/PR negative and more rapidly progressing (Brown et al., 2000; Holdaway and Bowditch, 1983; Kuukasjarvi et al., 1996; Osborne, 1985) . Indeed, there is increasing evidence that ERpositive and ER-negative breast cancers arise from dierent cell populations in the mammary gland, which either express steroid hormone receptors, or are ER/PR negative but express the EGFR (Clarke et al., 1997) . This hypothesis is in keeping with the often-observed inverse correlation between expression of ER and EGFR (Battaglia et al., 1988; Toi et al., 1989) . Furthermore, EGFR overexpression in breast cancer has been repeatedly shown to be an indicator of poor prognosis Nicholson et al., 1990 and reviewed in Salomon et al., 2000) . Given that premenopausal breast cancer tends to be highly aggressive, ER negative, and EGFR positive, understanding the basis and functional consequences of EGFR overexpression in breast cancer is important. This is particularly true because in breast cancer, unlike gliomas and other cancer types (Ekstrand et al., 1994; Nishikawa et al., 1994; Schlegel et al., 1994) . EGFR is overexpressed in the absence of gene ampli®cation (Nicholson et al., 1988 , suggesting that other genetic alterations present in these cells result in overexpression of the EGFR.
Overexpression of growth factor receptors can render mammary epithelial cells independent of growth factors required by normal mammary epithelial cells for growth under serum-free conditions. We have also shown that in both rat and human mammary epithelial cells the acquisition of progressive growth factor independence correlates with increasing aggressiveness in vivo (Ethier, 1995) . The phenotype of growth factor independence in rat and human breast cancer cells is not only a hallmark of their transformed growth potential, but can be induced by overexpression of growth factor receptors such as ERBB-2 .
To explore the mechanistic connection between EGF-independence in vitro and overexpression of the EGFR, we developed an expression cloning strategy aimed at the functional identi®cation of genes expressed in EGFR-overexpressing breast cancer cells that can transform normal HME cells to EGF independence. To perform these studies we made use of a breast cancer cell line developed in our laboratory from an aggressive primary breast cancer of a premenopausal patient. This SUM-149PT cell line forms foci in soft agar and is invasive in vitro . In addition, SUM-149PT cells are tumorigenic and spontaneously metastatic in nude mice (D Welch, personal communication) . These cells overexpress EGFR at the protein level in the absence of gene ampli®cation and the receptor is constitutively tyrosine phosphorylated when the cells are cultured in serum-free and EGF-free medium. SUM-149PT cells are EGF-independent for growth in vitro, and experiments using EGFR-speci®c kinase inhibitors demonstrated the requirement of EGFR signaling for the transformed phenotypes expressed by these cells (Rao et al., 2000) . Genetic analysis indicated that SUM-149PT cells do not have an ampli®cation of the EGFR gene, or other common breast cancer oncogenes such as ERBB-2, c-MYC, ®broblast growth factor receptor-1 or ®broblast growth factor receptor-2. Furthermore, while comparative genomic hybridization experiments revealed many areas of gene ampli®cation in these cells, the loci of other candidate breast cancer oncogenes are not ampli®ed in these cells (Forozan et al., 1999) . Thus, SUM-149PT cells are ideally suited for experiments aimed at understanding the genetic basis of EGFR overexpression in human breast cancer cells.
We produced a high-titer amphotropic retroviral cDNA expression library from the SUM-149PT cell line, and transduced this library into growth factordependent HME cells. Recipient cells were functionally selected for their ability to proliferate in serum-free medium in the absence of EGF. Library cDNAs were recovered from EGF-independent cell clones by PCR ampli®cation or using biological rescue, and tested for their ability to induce EGF autonomy. Using this approach, we have isolated the amphiregulin cDNA and demonstrated that this EGFR ligand mediates EGF autonomy of SUM-149PT cells.
Results
Expression cloning strategy to identify proteins that mediate EGF-independent growth of human breast cancer cells
As one of the key events in the progression of HME cells towards malignancy is the acquisition of growth factor independence, we decided to use an expression cloning strategy to seek gene products that mediate EGF-independent growth of EGFR-positive human breast cancer cells. Figure 1A shows a¯ow chart of our experimental plan. To generate the expression library, cDNAs from SUM-149PT EGF-independent breast cancer cells were directionally cloned into the pBabeMN retroviral vector as described in the Materials and methods section. The library was ampli®ed on agar plates and puri®ed plasmid DNA was transfected into FNX-Ampho packaging cells to generate a retroviral library stock. This retroviral Figure 1 Expression cloning strategy to identify genes involved in EGF independence of breast cancer cells. (A) An amphotropic retroviral expression library produced from SUM-149PT breast cancer cells was transduced into growth factor-dependent HME cells. Recipient cells were functionally selected for their ability to proliferate in serum-free medium in the absence of EGF. Several EGF-independent cell clones were obtained from which library cDNAs were recovered by PCR ampli®cation and sequenced. Additionally, cDNAs were rescued by transfecting EGF-independent cell clones with a plasmid encoding Moloney murine leukemia virus structural proteins. The resulting viral stock was used to infect ecotropic receptor-positive HME cells, which were then selected in EGF-free medium. Individual PCR-cloned cDNAs were also tested functionally by transduction into HME cells. (B) EGF-independent clones isolated after infection with the SUM-149PT retroviral library and selection for 6 ± 8 weeks in serum free, EGF-free medium. stock was used to infect MCF-10A or H16N2 HME cell lines, which are immortal but otherwise close to normal both genotypically and in regards to growth requirements in vitro. MCF-10A cells underwent spontaneous immortalization in culture, and are strictly dependent on EGF for growth in serum-free medium (Eithier et al., 1991; Soule et al., 1990) . H16N2 cells were immortalized by infection with HPV-16 in vitro (Band and Sager, 1989; Band et al., 1990) , and can grow in serum-free medium supplemented either with EGF or IGF but not in medium lacking both growth factors. The presence of HPV-16 gene products, namely E5, E6 and E7, could be responsible for the relaxed growth requirements of this cell line (zur Hausen, 1999) . We decided to include this line because, in our experience, cells expressing E6 and E7 are easier to transform than MCF-10A , presumably due to the inactivation of p53 and pRb tumor suppressor gene products.
Isolation of EGF-independent clones after infecting HME cells with the SUM-149PT retroviral library Library-infected MCF-10A cells were seeded at low density and selected in serum-free F-12 medium supplemented with insulin and hydrocortisone but without EGF (SFIH). Library-infected H16N2 cells were selected in a similar medium without insulin and EGF (SFH). After 6 to 8 weeks of selection, several colonies from both recipient cell lines were isolated by ring cloning. Six of these colonies that were successfully propagated for multiple passages in EGF-free medium were characterized ( Figure 1B ). Clones M4a#1, M5a#1 and M14a#106 were derived from MCF-10A cells, whereas clones H55a#1, H56b#2 and H58b#1 were derived from H16N2 cells. In contrast to library-infected colonies, pBabeMN-lacZ-infected cells either died or failed to grow in EGF-free medium, while some cells formed small colonies that did not grow further upon prolonged culture in EGF-free medium. Since we have never been able to obtain an EGF-independent colony from mock-infected cells or cells infected with lacZ control, we estimate the background of spontaneous occurrence of the EGF-independent phenotype to be less than one in 10 8 cells. This observation is consistent with the strict growth factor requirement of HME cells in serum-free media that we have reported previously (Ethier et al., 1990a (Ethier et al., , 1991 Ram et al., 1995) .
In order to recover library inserts from the EGFindependent colonies, we isolated genomic DNA or total RNA from these colonies and performed PCR ampli®cation using primers¯anking the cloning site in the pBabeMN retroviral vector. We were able to amplify between 2 and 6 cDNA inserts from each of ®ve colonies. These colonies were transduced with an average of four recombinant retroviral clones, which con®rms the high library titer. However, clone H58b#1 produced no insert in several PCR reactions. Recovered cDNA inserts ranged in size from 0.4 to 2.0 kb. Inserts were subcloned into pCR-Script SK + or pBabeMN plasmid for sequencing. Each of the inserts sequenced contained a poly(A) + tail and was¯anked by the expected vector sequences.
Functional analysis of candidate inserts
To determine if the genes integrated into the selected colonies are responsible for the EGF-independent phenotype, two dierent approaches were used. First, a biological rescue approach was employed in which EGF-independent cell clones were transfected with pMLV C-, a plasmid expressing the Moloney Murine Leukemia Virus Gag, Pol and Env proteins. This allowed the cell clones to package integrated provirus into viral particles which were collected and used to infect HME cells expressing the ecotropic receptor. In the second approach, individual PCR-ampli®ed cDNAs were subcloned into pBabeMN retroviral vector and used to infect new recipient cells. If the cell clones became EGF independent as a result of expressing one of the library cDNAs, then the retrovirus rescued either biologically or by PCR cloning should transfer the ability to grow in the absence of EGF to new recipient cells.
Using both approaches described above, we were unable to reproduce the EGF-independent phenotype by rescuing inserts from clones M4a#1, M5a#1 or M14a#106. Rescue also failed when combinations of any two cDNAs from one clone were co-infected into recipient cells. We obtained a few colonies in the M5a#1 rescue experiment, but they were not truly EGF independent as they stopped growing before reaching con¯uence in serum-free, EGF-free medium. These colonies did not select for a particular cDNA insert, as all six original PCR fragments were seen in a pooled population of cells ( Figure 2B , lane 4). In contrast, we recovered many EGF-independent colonies using biologically rescued virus from the H16N2-derived H55a#1 clone ( Figure 2A ). We con®rmed that this re¯ected genuine rescue by picking individual colonies and performing RT ± PCR. As shown on Figure 2B (lanes 7 ± 12), all of the secondary colonies contained the same 1.8 kb PCR fragment. The PCR fragment from two colonies was sequenced directly and corresponded to amphiregulin. Moreover, the amphiregulin cDNA ampli®ed from H55a#1 cells was sucient to induce the EGF-independent phenotype when used to infect either MCF-10A or H16N2 HME cells ( Figure 2A ). Furthermore, cells transduced with amphiregulin remained EGF independent when subcultured in vitro. In an independent library screening experiment, we have isolated eight additional EGFindependent clones, of which three contained amphiregulin inserts (data not shown). Thus, four out of fourteen colonies (28%) owed their EGF autonomy to amphiregulin. Clone H56b#2 yielded another cDNA able to transform HME cells to EGF independence. This cDNA is currently under investigation and will be described elsewhere.
Role of amphiregulin in EGF independence of H55a cell clone and SUM-149PT parental cells
The fact that the amphiregulin cDNA yielded EGF independent growth was consistent with its characterization as an activating ligand for EGFR (Johnson et al., 1993) . To determine if amphiregulin plays an autocrine role in SUM-149PT breast cancer cells, we examined the status of the amphiregulin gene in SUM-149PT cells and in the EGF-independent cell clones. Southern blot analysis was performed to determine whether the amphiregulin locus was ampli®ed in SUM-149PT ( Figure 3a ). These cells and H16N2 cells contained two dierent alleles, whereas MCF-10A cells contained two identical alleles. Clone H55a#1 showed the same two alleles as parental H16N2 cells, with an additional band representing the integrated provirus. Quanti®cation using a PhosphorImager screen indicated that there was no gene ampli®cation in SUM-149PT cells. However, the SUM-149PT cells expressed high levels of the amphiregulin transcript compared to MCF-10A and H16N2 cells (Figure 3b ). In addition, clone H55a#1 produced high levels of larger molecular weight mRNA transcribed from the retroviral LTR. Amphiregulin mRNA was also detected by Northern blot in ®ve out of 10 breast cancer cell lines developed in our laboratory, and was highest in the SUM-229PE cell line (Figure 3b , lane 6), which also overexpresses the EGFR and is EGF independent for growth in serum-free medium ( Figure 6a ) and data not shown). The presence of elevated transcript levels in SUM-149PT and H55a#1 cells suggests that amphiregulin might be secreted from these cells and play an autocrine role. Therefore, we assessed EGF-like growth factor activity in the conditioned medium from SUM-149PT and H55a#1 cells using H16N2 as indicator cells. As shown in Figure 3c , moderate growth factor activity was detected in SUM-149PT and H55a#1 conditioned medium when using H16N2 as indicator cells. The same conditioned medium was inactive when MCF-10A cells were used as indicators, suggesting a dierence in the sensitivity of the two HME cell lines to amphiregulin. Indeed, the dose-response curve for H16N2 growth stimulation by recombinant amphiregulin was steeper than the MCF-10A curve ( Figure  3d ). Thus, conditioned medium concentrations of amphiregulin lower than 10 ng/ml would fail to be detected using MCF-10A cells but would stimulate H16N2 cells to the same extent as EGF.
Structure of the amphiregulin cDNA recovered from H55a#1 cells
Sequencing of the amphiregulin cDNA ampli®ed from both the original H55a#1 cell clone and the secondary clones derived from the biological rescue experiments, revealed a 40 bp insertion in the coding region. Part of the inserted sequence matched the retroviral vector, and was¯anked by a 14 bp repeat of amphiregulin sequences (Figure 4a ). To determine if these additional sequences might be present in the SUM-149PT parental cell line or in the plasmid library made from these cells, we designed two primers¯anking the insertion site for RT ± PCR analysis. The product should shift from 276 ± 330 bp when the extraneous sequences are present. As expected, the larger PCR product was detected when using H55a#1 RNA as template (Figure 4b, lane 4) , but only the shorter product, representing wild-type amphiregulin, was seen in H16N2 and SUM-149PT cells or SUM-149PT library DNA (Figure 4b, lanes 3, 5 and 6 ). This result suggested that the insertion might be an artifact of the infection with the retroviral library.
The consequence of having the insertion in the coding region of amphiregulin was next investigated. The extra 54 bp (40 bp insertion +14 bp repeat) would be predicted to encode 18 new amino acids and leave the reading frame unchanged. These additional amino acids would be inserted two residues before the Cterminal end of the mature amphiregulin polypeptide, potentially altering its proteolytic processing or its growth factor activity. To determine if the amphiregulin cDNA recovered from H55a#1 cells behaves abnormally, we cloned wild-type amphiregulin by RT ± PCR and transduced it into MCF-10A or H16N2 HME cells via two dierent retroviral constructs. We found that overexpression of wild type amphiregulin is sucient to confer EGF independence upon both cell lines (Figure 2a and data not shown) . Moreover, the amphiregulin cDNA found in three other EGFindependent clones did not contain the 54 bp insertion when assayed by RT ± PCR (data not shown). Thus, the additional sequences in the H55a#1 clone do not appear to be responsible for the ability of amphiregulin to yield EGF-independent growth. WT1, the Wilms' tumor suppressor gene, is not responsible for amphiregulin overexpression in SUM-149PT cells Amphiregulin is a target of the WT1 transcription factor in osteosarcoma cells, and both proteins are temporally and spatially co-expressed in the developing kidney (Lee et al., 1999) . In addition, WT1 is expressed in normal HME cells and in some breast cancer cells (Silberstein et al., 1997) . Interestingly, comparative genomic hybridization analysis of SUM-149PT detected an ampli®cation encompassing the WT1 locus on chromosome 11p13 (Forozan et al., 1999) . Therefore, we performed a Southern blot hybridization to determine whether WT1 was ampli®ed in SUM-149PT cells. In spite of the cytogenetic results, no ampli®cation was detected at the gene level (Figure 5a) . A WT1 splice variant lacking three amino acids (7KTS), has been described to activate the amphiregulin promoter, whereas the WT1(+KTS) isoform was inactive (Lee et al., 1999) . To investigate the expression of the WT1(7KTS) isoform in SUM-149PT, H16N2 and MCF-10A cells, we performed RT ± PCR analyses using primers that¯ank the 9 bp splice region. The expected products are 119 bp for the (7KTS) variant and 128 bp for the (+KTS) variant. We detected both splice variants in H16N2 and SUM-149PT and an additional, slightly larger form, but failed to detect any WT1 product in MCF-10A cells (Figure 5b ). Since MCF-10A (Figure 3b) , there was no simple correlation between the expression of WT1(7KTS) and the level of amphiregulin transcripts. Thus, it is unlikely that WT1 by itself mediates the increase in amphiregulin levels of SUM-149PT cells.
EGFR levels and activity in amphiregulin-overexpressing cells
Because amphiregulin is overexpressed in the EGFindependent SUM-149PT, H55a#1 and SUM-229PE cells, EGFR might be expected to be active in the absence of exogenous ligands. As shown on Figure 6a , EGFR levels in whole cell lysates from SUM-149PT, H55a#1 and SUM-229PE cells were elevated compared to H16N2 cells (bottom right panel). Moreover, EGFR was constitutively phosphorylated on tyrosine residues as shown by reciprocal EGFR and phosphotyrosine immunoprecipitations followed by immunoblotting (Figure 6a , top panels). In order to determine whether H55a#1 cells were strictly dependent on the EGFR pathway, we performed growth assays in the presence of CI-1033 (formerly PD183805), a small molecule kinase inhibitor speci®c for ErbB family receptors and with no activity against other tyrosine kinases (Fry et al., 1994 (Fry et al., , 1998 Smaill et al., 2000) . We have previously shown that this inhibitor blocks the growth of SUM-149PT cells and two breast cancer cell lines with ErbB-2 ampli®cations, but had no eect on cells which do not express activated ErbB kinases (Rao et al., 2000) . Since no other ErbB family members are phosphorylated in the SUM-149PT donor cell line or clone H55a#1 (as shown by the absence of bands above EGFR on the phosphotyrosine immunoblots), any eect of CI-1033 can be attributed to EGFR inhibition. CI-1033 was able to inhibit the growth of H55a#1 cells (Figure 6b ), con®rming that these cells require activated EGFR in order to grow in the absence of EGF. Therefore, both the SUM-149PT donor cell line and clone H55a#1 contain the essential elements of an amphiregulin-EGFR autocrine loop.
Discussion
The SUM-149PT cell line is representative of the subset of breast cancer characterized by EGFR overexpression and estrogen receptor negativity. We have utilized this cell line in a functional screening approach to identify candidate genes responsible for the acquisition of phenotypic features of breast cancer cells. Our ®rst screening focused on the phenotype of EGF independence for growth in serum-free medium. We have previously shown that this phenotype is correlated with increasing aggressiveness of rat and human mammary cancer cells (Ethier et al., 1987 (Ethier et al., , 1990b . The high transduction eciency that can be achieved with retroviral expression vectors allowed us to screen large numbers of HME cells infected with the SUM-149PT cDNA library. Retroviral cDNA-based functional cloning has been used successfully to identify oncogenes and apoptosis regulators (Hitoshi et al., 1998; Whitehead et al., 1995) .
Despite the low background of spontaneous EGF independence of HME cells, only some of the EGFindependent clones contained an insert that could transfer the phenotype to new cells. Other clones contained inserts that were unable to confer EGF independence to new cells either in biological rescue experiments or when transduced separately after PCR cloning. In these clones, biological rescue and PCR ampli®cation may have failed due to a deletion or mutation in retroviral sequences. Alternatively, proviruses may have integrated near or within critical growth-regulating genes and either inactivated them by insertional mutagenesis or activated their transcription via the LTR. There may also be other non-genetic but sustained eects of infection or truly spontaneous acquisition of EGF independence. However, no EGFindependent clones were obtained from control virusinfected cells. The reason why cDNA inserts recovered from EGF-independent MCF-10A clones could not confer EGF autonomy upon naõÈ ve cells is not entirely clear but is under investigation. Somatic cell hybrid experiments, which will be published elsewhere, have indicated that EGF independence is dominantly inheritable in some clones and recessive in other clones. EGF-independent clones containing the amphiregulin insert were isolated when H16N2 cells were used as recipient cells but not when MCF-10A cells were used. This could be due to the dierential sensitivity of H16N2 and MCF-10A cells to amphiregulin. Since selection for EGF-independent growth takes place at very low densities in our experiments, local concentrations of secreted amphiregulin were probably never high enough to stimulate true autocrine growth of MCF-10A cells when transduced with the library. By contrast, infection of MCF-10A cells with a high-titer amphiregulin retroviral stock did result in ecient autocrine stimulation of these cells.
We isolated amphiregulin from the H55a#1 EGFindependent cell clone. Amphiregulin is a member of the EGF family of growth factors, which include at least six EGFR ligands (Salomon et al., 2000) . We were able to induce EGF independence in MCF-10A and H16N2 cells by infecting these cells with retrovirus rescued from the H55a#1 clone. As expected, each of the EGFindependent clones obtained in the rescue experiment contained the amphiregulin insert. Moreover, direct transfection or infection with cloned amphiregulin constructs also induced EGF independence of both H16N2 and MCF-10A cells. In addition, three independently isolated clones selected on the basis of their EGF autonomy were found to contain the amphiregulin cDNA, which could also be rescued biologically. The fact that we repeatedly isolated the amphiregulin gene using a functional screening strategy con®rms the important role of this ligand in the acquisition of autonomous growth in SUM-149PT cells. By Northern blot analyses, these cells expressed very low levels of heparin binding EGF-like growth factor, and EGF or TGF-a were undetectable (data not shown), but the contribution of other growth factors in stimulating proliferation cannot be ruled out completely. It is clear that amphiregulin expression is not the only possible mechanism by which HME cells can become EGF independent, and another donor breast cancer cell line might give dierent results. We have shown that erbB-2-overexpressing breast cancer cells are EGF independent in culture and this phenotype was acquired by HME cells when erbB-2 was transduced using a retroviral expression vector . Similarly, FGFR2 overexpression, which occurs in the SUM-52 breast cancer cells, also confers EGF-independence in vitro (Tannheimer et al., 2000) . Finally, several EGF-independent clones isolated in the present study acquired the phenotype by mechanisms that do not involve amphiregulin. Thus, many dierent genetic alterations in dierent breast cancer cells can result in the same altered phenotype. It is interesting to note, however, that the SUM-229PE cell line, which is similar in many respects to the SUM-149PT cells, also expresses high levels of amphiregulin message. Thus, it is possible that amphiregulin expression is a common mode of growth factor autonomy in that subset of breast cancers in which EGFR levels are elevated, and in which other erbB family members are not overexpressed or activated.
Amphiregulin is overexpressed in SUM-149PT breast cancer cells, but the gene is not ampli®ed in these cells. This raises the question of the genetic basis for amphiregulin overexpression in SUM-149PT cells. A few physiological and pharmacological regulators of amphiregulin gene expression have been reported. Members of the EGF family of growth factors induce each other's expression (Barnard et al., 1994) . In addition, estradiol directly stimulates amphiregulin transcription (MartõÂ nez-Lacaci et al., 1995). However, most EGFR-positive breast cancer cells, including SUM-149PT, do not express the estrogen receptor. TPA induces amphiregulin expression in the absence of a consensus TPA-responsive element in its promoter region (Plowman et al., 1990) . TPA induction occurs via activation of protein kinase C, requires new protein synthesis, and is at least in part mediated by mRNA stabilization (MartõÂ nez-Lacaci et al., 1995) . The WT1 transcription factor, speci®cally the WT1(7KTS) isoform, was recently shown to activate amphiregulin expression (Lee et al., 1999) . WT1 tends to be expressed at high levels in advanced, ER-negative breast tumors, and the (7KTS) isoform was reported to be expressed more often in tumors than normal breast tissue (Silberstein et al., 1997) . However, WT1 was not ampli®ed in SUM-149PT, and we found no correlation between the expression of WT1(7KTS) and the level of amphiregulin mRNA in MCF-10A, H16N2 and SUM-149PT cell lines. Therefore, the mechanism for amphiregulin induction in SUM-149PT cells remains to be elucidated.
The conditioned medium recovered from SUM-149PT and H55a#1 cells stimulated H16N2 growth moderately, suggesting that low concentrations of amphiregulin are released in the medium. Amphiregulin could also exist as a membrane precursor in SUM-149PT and H55a#1 cells (Plowman et al., 1990) , and play a juxtacrine role in addition to an autocrine role. The expression of elevated levels of a growth factor is necessary but not sucient for the establishment of an autocrine/juxtacrine loop in tumor cells. In addition, the cognate receptor must be expressed by the tumor cells, and their growth must be dependent on the growth factor (Ethier, 1995) . The SUM-149PT and H55a#1 cells ful®ll these requirements, since they express high levels of both amphiregulin and EGFR, and require the EGFR kinase activity for monolayer growth in serum-free EGF-free medium. Several descriptive studies have investigated possible associations between amphiregulin expression and clinical parameters of breast cancer. For example, amphiregulin was found in 35 ± 73% of EGFR-positive breast cancer cases (LeJeune et al., 1993) , setting the stage for autocrine growth. However, another subset of cases expressed either amphiregulin or EGFR but not both. Stromal staining for amphiregulin was also observed in breast cancer samples, suggesting a cooperative relationship between stroma and neoplastic epithelial cells (LeJeune et al., 1993) . Depending on the study, amphiregulin expression in breast cancer tissues was associated with various clinicopathological parameters such as nodal status, estrogen receptor positivity, p53 mutations, invasive behavior and outcome (LeJeune et al., 1993; Normanno et al., 1995; Qi et al., 1994; Visscher et al., 1997) . There is far less mechanistic information that sheds light on how amphiregulin might actually contribute to the molecular pathogenesis of breast cancer. A role for amphiregulin in early malignant progression of mammary tumors is supported by the fact that overexpression of this growth factor leads to hyperplasia of murine ductal mammary epithelium in vivo (Kenney et al., 1996) . Furthermore, antisense amphiregulin constructs were able to reduce anchorage-independent growth of a tumorigenic cell line derived from SV40 T antigen-immortalized HME cells, and reduced tumor intake, mass and vascularization of the same cells in vivo (Ma et al., 1999) . Our ®ndings provide another direct line of evidence for a role for amphiregulin in stimulating the proliferation of EGFR-overexpressing HME cells, and suggest that it plays a role in the etiology of at least a subset of human breast cancers.
Materials and methods

Cell culture
SUM-149PT and SUM-229PE cells were maintained in Ham's F-12 with 5% fetal bovine serum, 5 mg/ml insulin, 2 mg/ml hydrocortisone, 5 mg/ml gentamicin and 2.5 mg/ml fungizone. The serum-free base medium for HME cell and derived clones was SFH: Ham's F-12, with 1 mg/ml hydrocortisone, 1 mg/ml bovine serum albumin, 10 mM N-[2-hydroxyethyl]piperazine-N'-[2-ethanesulfonic acid], 5 mM ethanolamine, 5 mg/ml transferrin, 10 nM triiodothyronine, 50 nM sodium selenate, 5 mg/ml gentamicin and 2.5 mg/ml fungizone. MCF-10A and H16N2 cells were maintained in SFH medium supplemented with 5 mg/ml insulin and 10 ng/ ml EGF (SFIHE). FNX-Ampho producer cells (Hitoshi et al., 1998) were grown in DMEM supplemented with 10% fetal bovine serum, 1% glutamine, 5 mg/ml gentamicin, and 2.5 mg/ml Fungizone. All cells were maintained in a humidi®ed incubator at 378C and 10% CO 2 .
cDNA library construction
Poly(A + ) RNA was isolated from SUM-149PT breast cancer cells using the FastTrack 2.0 kit (Invitrogen, Carlsbad, CA, USA). The TimeSaver cDNA synthesis kit was used with the Directional Cloning Toolbox (Pharmacia, Piscataway, NJ, USA) to synthesize cDNA from 5 mg polyadenylated RNA. Vector was prepared by digesting pBabeMN-Z (Kinoshita et al., 1997) with NotI and EcoRI restriction endonucleases. cDNA fragments of *0.5 to 8 kb were size-fractionated and ligated with 500 ng vector fragment using the DNA ligation kit from Takara Shuzo (Kyoto, Japan). Ligation mix was precipitated with ethanol and electroporated into ElectroMax DH10B bacterial cells (Life Technologies, Gaithersburg, MD, USA). Transformants were plated onto 150 mm LB/agar Petri dishes containing 20 mg/ml ampicillin and 80 mg/ml methicillin, then grown overnight at 378C. Bacterial colonies were collected and plasmid DNA was prepared by standard methods. The resulting plasmid library had a complexity of 5.1610 5 independent colonies, of which approximately 82% had an insert, with an average size of 0.9 kb.
Production of retrovirus stock and infection
FNX-Ampho producer cells were transfected with 7.5 ± 10 mg plasmid per 60 mm plate using the calcium phosphate/DNA co-precipitation method (Pear et al., 1993) . Forty-eight hours post-transfection, retrovirus-containing supernatants were collected and ®ltered through a 0.45 mm ®lter. Twenty-®ve million MCF-10A or H16N2 recipient cells were infected with 3 ml virus stock per 100 mm dish in the presence of 5 mg/ml polybrene and incubated at 378C. Viral titer was approximately 2610 6 cfu/ml as determined by infection of recipient cells with pBabeMN-lacZ control viral stock and staining with 5-Bromo-4-chloro-3-indoyl-b-D-galactopyranoside (Roche, Indianapolis, IN, USA). Control infections with pBabeMN-lacZ virus performed in parallel with library infections indicated that 50 ± 80% of cells were routinely infected. Twenty-four hours post-infection, cells were split 1 : 6 in serum-free medium without EGF for selection. Colonies were isolated by ring cloning and propagated in the same media for subsequent assays, unless noted otherwise.
PCR and sequencing
PCR ampli®cation of integrated cDNA was performed either with genomic DNA or with RNA that was reverse-transcribed with Superscript II (Life Technologies, Gaithersburg, MD, USA) using a retroviral vector-speci®c downstream primer (5'-GGTGGGGTCTTTCATTCC). DNA was ampli®ed with the same downstream primer and an upstream retroviral vector primer (5'-CAGCCCTCACTCCTTCTC) as described (Kitamura et al., 1995) except that the AccuTaq LA polymerase (Sigma, St Louis, MO, USA) was used. As a positive control for RT ± PCR, we used RNA from a pBabeMN-lacZ infected MCF-10A cell clone (MCF-Z) isolated in medium with EGF. The expected PCR product from MCF-Z control cells is 3.9 kb. PCR fragments were subcloned into pCR-Script SK + (Stratagene, La Jolla, CA, USA) or pBabeMN, and sequenced at the University of Michigan DNA sequencing core. GenBank sequence database was searched for similarities with ampli®ed fragments using BLAST. PCR ampli®cation of amphiregulin was performed with primers P1 (5'-GA-TAAACCCAAAAGAAAGAAAAAG) and P2 (5'-GAG-GATCACAGCAGACATAAAG) as above except that the annealing temperature was 518C. For WT1 RT ± PCR, mRNAs were reverse-transcribed with primer WTR2 (5'-AAAGTAGGCAGGGCAGAGACCAAC), then PCR was performed with primer WTF5 (5'-TCCGACCACCTGAA-GACC) and WTR6 (5'-ATGTTGTGATGGCGGACTAA), with a 538C annealing temperature. A (7KTS) control was obtained from FNX-A kidney cells by RT ± PCR, cloned into pCR-Script SK + , and sequenced to con®rm the splicing type. The expected product from the control is 119 bp. The amphiregulin and WT1 RT ± PCR products were separated on 2 and 4% Nusieve 3 : 1 agarose gels (FMC Bioproducts, Rockland, ME, USA), respectively.
Functional analysis of candidate inserts
In order to pseudotype MCF-10A and H16N2 cells, FNXAmpho cells were transfected with the ecotropic receptor in pM5 vector and the resulting retrovirus stock was used to infect MCF-10A and H16N2 cells as described above. ER ± MCF-10A and ER ± H16N2 ecotropic receptor-expressing cells were selected with 100 mg/ml G418 (Life Technologies, Gaithersburg, MD, USA) for at least 2 weeks. For the biological rescue of library inserts, EGF-independent cell clones were transfected with pMLV C- (Pfeier et al., 1999 ; a kind gift from Dr A Telesnitsky) using FuGENE 6 (Roche, Indianapolis, IN, USA). Media were collected and used to infect ER-MCF-10A or ER-H16N2 cells, which were then selected in SFIH or SFH, respectively. Alternatively, individual PCR-ampli®ed cDNAs subcloned into pBabeMN retroviral vector were used individually or pairwise to infect virgin MCF-10A or H16N2 cells following the same protocol as for the library screening.
Southern and Northern blot hybridizations
Genomic DNA (5 mg/lane) was digested with BamHI and EcoRI restriction endonucleases, fractionated on 0.8% agarose gels and transferred to a Nytran membrane (Schleicher & Schuell, Keene, NH, USA). A 0.9 kb amphiregulin cDNA probe (a kind gift from Drs S Stoll and JT Elder) was radiolabeled by random priming and used in Southern blot hybridizations as described previously (Ram and Ethier, 1996) . After autoradiography and quanti®cation using a Storm Phosphor Screen (Molecular Dynamics, Amersham Pharmacia Biotech, Piscataway, NJ, USA), the membrane was stripped and reprobed with glyceraldehyde 3-phosphodehydrogenase (GAPDH) as a loading control. The same membrane was stripped again and reprobed with a 1 kb WT1 probe obtained from FNX-A kidney cells by RT ± PCR and veri®ed by sequencing. For Northern blot analysis, 10 mg total cellular RNA prepared with Trizol (Life Technologies, Gaithersburg, MD, USA) was fractionated on 0.8% agarose formaldehyde gels, transferred to a Nytran membrane, and hybridized to the amphiregulin and GAPDH probes.
Assay for EGF-like growth factor activity in conditioned medium and amphiregulin growth-response curve Conditioned media from subcon¯uent SUM-149PT and H55a#1 cultures were collected 48 h after feedings. For this assay, SUM-149PT cells were grown in SFIH to remove the possible growth stimulatory contribution of fetal bovine serum. H16N2 or MCF-10A cells were seeded in 6-well plates at 3.5610 4 cells/well and grown in SFIH medium or SFIH supplemented 1 : 1 with conditioned medium. Insulin was adjusted in all samples to equal the concentration in SFIH. For the growth-response curve, HME cells were treated with SFIH supplemented with 1 ± 100 ng/ml recombinant human amphiregulin (Sigma, Saint Louis, MO, USA). After 8 days, cell counts were determined using a Coulter Counter (Miami, FL, USA).
Immunoprecipitations and immunoblotting
Whole cell protein extracts were prepared as described previously . For immunoprecipitations, 1 mg aliquots of cell extracts were incubated for 2 h at 48C with 1 mg anti-EGFR AB-5 (Oncogene Research Products, Boston, MA, USA) or 1 mg each anti-phosphotyrosine antibodies 4G10 (Upstate Biotechnology, Lake Placid, NY, USA) and PY-20 (ICN Biochemicals Inc., Aurora, OH, USA). The immune complexes were bound to protein A/G beads (Calbiochem, Cambridge, MA, USA) for 1 h at 48C. Immunoprecipitates were washed three times with lysis buer, boiled in loading buer and loaded onto 6% SDS-polyacrylamide gels. Two hundred mg whole cell extracts were also loaded for comparison. Following electrophoresis, proteins were electroblotted onto Immobilon-P PVDF membranes (Millipore, Bedford, MA, USA) and developed with anti-EGFR antibody 31G7 (Zymed Laboratories, San Francisco, CA, USA) and anti-phosphotyrosine antibody 4G10 using the Vectastain ABC reagent (Vector Laboratories, Burlingame, CA, USA).
ErbB kinase inhibitor growth assays
Cells were seeded in 6-well plates at 5610 4 cells/well on day 0. Parental H16N2 cells were grown in SFIHE and clone H55a#1 was grown in SFH. Cultures were treated on days 4, 6 and 8 with 0.1 or 1 mM CI-1033 ErbB kinase inhibitor (a generous gift from Drs W Leopold and D Fry, P®zer, Parke Davis Division, Ann Arbor, MI, USA) or 0.1% dimethyl sulphoxide (DMSO) as vehicle control. Cells were counted in triplicate on day 1 and every 3 days thereafter using a Coulter Counter (Miami, FL, USA).
